The Bordetella effector protein BteA induces host cell death by disruption of calcium homeostasis
Martin ZmudaiD, Eliska Sedlackova, Barbora Pravdova, Monika ČížkováiD, Markéta DaleckáiD, Ondřej ČernýiD, Tania Romero Allsop, Tomáš GroušliD, Ivana MalcováiD, Jana KamanováiD
Abstract
Bordetella pertussis is the causative agent of whooping cough in humans, a disease that has recently experienced a resurgence. In contrast, Bordetella bronchiseptica infects the respiratory tract of various mammalian species, causing a range of symptoms from asymptomatic chronic carriage to acute illness. Both pathogens utilize type III secretion system (T3SS) to deliver the effector protein BteA into host cells. Once injected, BteA triggers a cascade of events leading to caspase 1-independent necrosis through a mechanism that remains incompletely understood. We demonstrate that BteA-induced cell death is characterized by the fragmentation of the cellular endoplasmic reticulum and mitochondria, the formation of necrotic balloon-like protrusions, and plasma membrane permeabilization. Importantly, genome-wide CRISPR-Cas9 screen targeting 19,050 genes failed to identify any host factors required for BteA cytotoxicity, suggesting that BteA does not require a single nonessential host factor for its cytotoxicity. We further reveal that BteA triggers rapid and sustained influx of calcium ions, which is associated with organelle fragmentation and plasma membrane permeabilization. The sustained elevation of cytosolic Ca2+ levels results in mitochondrial calcium overload, mitochondrial swelling, cristolysis, and loss of mitochondrial membrane potential. Inhibition of calcium channels with 2-APB delays both the Ca2+ influx and BteA-induced cell death. Our findings indicate that BteA exploits essential host processes and/or redundant pathways to disrupt calcium homeostasis and mitochondrial function, ultimately leading to host cell death. ImportanceThe respiratory pathogens, Bordetella pertussis and Bordetella bronchiseptica, exhibit cytotoxicity towards a variety of mammalian cells, which depends on the type III secretion effector BteA. Moreover, the increased virulence of B. bronchiseptica is associated with enhanced expression of T3SS and BteA effector. However, the molecular mechanism underlying BteA cytotoxicity is elusive. In this study, we performed a CRISPR-Cas9 screen, revealing that BteA-induced cell death depends on essential or redundant host processes. Additionally, we demonstrate that BteA disrupts calcium homeostasis, which leads to mitochondrial dysfunction and cell death. These findings contribute to closing the gap in our understanding of the signaling cascades targeted by BteA.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 1.87
- Field percentile
- top 15%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cytotoxicity of the effector protein BteA was attenuated in Bordetella pertussis by insertion of an alanine residue
J. Bayram, I. Malcova, … J. Kamanova·PLOS PathogensPeer-reviewed·Aug 10, 2020
- Transcriptional Downregulation of a Type III Secretion System under Reducing Conditions in Bordetella pertussis
Masataka Goto, Tomoko Hanawa, … Asaomi Kuwae·bioRxiv·Apr 20, 2020
- Lipid binding by N-terminal motif mediates plasma membrane localization of Bordetella effector protein BteA
I. Malcova, L. Bumba, … J. Kamanova·bioRxiv·Nov 17, 2020
- Cytotoxicity and effector cooperation in the type III secretion system of Aeromonas schubertii
Hana Míchová, Jan Pliva, … Jana Kamanová·bioRxiv·Mar 21, 2025
- A type III secretion system is required for Bordetella atropi host cell invasion in vivo
Tuan D. Tran, Serena J. Meadows-Graves, … Robert J. Luallen·PLoS PathogensPeer-reviewed·Feb 13, 2026
- Limited response of primary nasal epithelial cells to Bordetella pertussis infection and the effector protein BteA
Martin Zmuda, Barbora Pravdova, … Jana Kamanová·bioRxiv·Feb 3, 2025